BIO Logo

Bio-Rad Laboratories, Inc. (BIO) 

NYSE
Market Cap
$9.57B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
438 of 963
Rank in Industry
58 of 120

Largest Insider Buys in Sector

BIO Stock Price History Chart

BIO Stock Performance

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Insider Activity of Bio-Rad Laboratories, Inc.

Over the last 12 months, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $358,992 worth of Bio-Rad Laboratories, Inc. stock.

On average, over the past 5 years, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $6.29M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500 shares for transaction amount of $109,792 was made by HINCKLEY GREGORY K (director) on 2017‑05‑26.

List of Insider Buy and Sell Transactions, Bio-Rad Laboratories, Inc.

2023-12-12SaleEVP, President, CDG
1,200
0.0042%
$299.16$358,992+9.96%
2023-11-28SaleEVP, GBL Commercial Operations
642
0.0022%
$305.10$195,874+5.79%
2023-08-30SaleEVP, General Counsel & Sec
2,350
0.0081%
$395.60$929,667-20.17%
2023-08-23SaleEVP, General Counsel & Sec
300
0.001%
$384.69$115,407-17.82%
2023-06-15SaleEVP, GBL Commercial Operations
500
0.0017%
$379.39$189,695-13.92%
2023-06-06SaleSVP, Chief Accounting Officer
198.35
0.0007%
$368.30$73,053-11.34%
2023-03-08SaleEVP, General Counsel & Sec
1,746
0.006%
$486.43$849,300-24.18%
2022-11-10SaleSVP, Chief Accounting Officer
379.38
0.0013%
$421.87$160,051-6.43%
2022-08-05SaleSVP, Chief Accounting Officer
518
0.0017%
$537.00$278,166-21.06%
2021-11-12SaleExecutive Vice President
4,800
0.016%
$750.05$3.6M-29.26%
2021-11-11SaleExecutive Vice President
1,546
0.0052%
$749.00$1.16M-28.86%
2021-09-03SaleEVP, Chief Financial Officer
270
0.0009%
$820.06$221,416-28.93%
2021-09-02SaleEVP, Chief Financial Officer
540
0.0018%
$828.00$447,121-29.43%
2021-09-01SaleEVP, Chief Operating Officer
2,000
0.0067%
$813.10$1.63M-28.42%
2021-08-26SaleExecutive Vice President
600
0.002%
$792.58$475,548-26.32%
2021-08-09SaleEVP, GBL Commercial Operations
3,000
0.01%
$754.93$2.26M-19.26%
2021-08-04SaleEVP, General Counsel & Sec
327
0.0011%
$760.26$248,605-19.02%
2021-08-04SaleEVP, Chief Financial Officer
2,300
0.0076%
$751.84$1.73M-19.02%
2021-02-19SaleEVP, General Counsel & Sec
923.11
0.0021%
$432.07$398,851+4.93%
2020-12-15SaleEVP, GBL Commercial Operations
374
0.0012%
$580.67$217,171+9.55%

Insider Historical Profitability

<0.0001%
WRIGHT DARAEVP, President, CDG
1499
0.0053%
$341.4901
SCHWARTZ ALICE Ndirector, 10 percent owner
1806651
6.4463%
$341.4912<0.0001%
SCHWARTZ NORMAN DChairman, President, and CEO
411252
1.4674%
$341.4903
GOETZ JOHNEVP, Chief Operating Officer
61174
0.2183%
$341.4909
BENNETT JAMESdirector
32546
0.1161%
$341.4903
Magni GiovanniEVP, Chief Strategy Officer
20738
0.074%
$341.49026
HERTIA JOHNExecutive Vice President
18728
0.0668%
$341.49011
WADLER SANFORDVP, General Counsel, Secretary
11936
0.0426%
$341.49020
SCHWARTZ DAVIDChairman of the Board
8753
0.0312%
$341.4910<0.0001%
Crowley MichaelEVP, GBL Commercial Operations
6942
0.0248%
$341.49021
TSINGOS CHRISTINE AEVP and CFO
6683
0.0238%
$341.49022
HILLMAN ALdirector
6252
0.0223%
$341.4901
CRUTCHFIELD BRADFORDExecutive Vice President
6023
0.0215%
$341.49011
TUMOLO ANNETTEExecutive Vice President
4593
0.0164%
$341.4907
HUTTON RONALD WVice President and Treasurer
4140
0.0148%
$341.49117<0.0001%
ERNST TIMOTHY SEVP, General Counsel & Sec
2416
0.0086%
$341.4909
SCHWARTZ STEVEN D10 percent owner
1818
0.0065%
$341.4904
Last Andrew J.EVP, Chief Operating Officer
1282
0.0046%
$341.4901
SODERBERG SHAWN MARIEEVP, General Counsel, Sec
652
0.0023%
$341.4905
Hall ShannonExecutive Vice President
565
0.002%
$341.4909
HINCKLEY GREGORY Kdirector
500
0.0018%
$341.4910+11%
STARK JAMES RVP, Corporate Controller
0
0%
$341.49127<0.0001%
Daskal IlanEVP, Chief Financial Officer
9
0%
$341.4903
RAMALINGAM AJITSVP, Chief Accounting Officer
0
0%
$341.4903

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$837.47M8.492.42M+1.32%+$10.88M0.02
BlackRock$511.85M5.191.48M+0.93%+$4.72M0.01
Veritas Asset Management LLP$396.75M4.021.15M+5.93%+$22.21M2.88
State Street$302.18M3.06873,675-0.14%-$428,532.930.01
EARNEST Partners$178.09M1.81514,906+30.81%+$41.94M0.82
Select Equity Group, L.P.$178.01M1.8514,666+167.47%+$111.45M0.64
Geode Capital Management$163.26M1.66473,201+2.85%+$4.52M0.01
Invesco$159.45M1.62461,006+0.71%+$1.13M0.03
Ubs Asset Management Americas Inc$146.01M1.48422,157-16.11%-$28.03M0.05
Investec Asset Management UK$145.47M1.48420,600New+$145.47M0.41
TSW (Thompson, Siegel & Walmsley LLC)$121.06M1.23350,014+0.44%+$532,984.161.87
Massachusetts Financial Services Co Ma$120.1M1.22347,252+7.74%+$8.63M0.04
Southeastern Asset Management$118.97M1.21343,959-5.52%-$6.95M4.57
Dimensional Fund Advisors$104.07M1.06300,904+37.04%+$28.13M0.03
Hound Partners Llc$91.5M0.93264,537+1.1%+$993,684.5127.27
Northern Trust$87.69M0.89253,533+0.45%+$393,600.060.01
Morgan Stanley$87.28M0.89252,340+0.91%+$784,782.030.01
Parnassus Investments Ca$82.24M0.83237,7900%+$00.18
Westfield Capital Management Co Lp$79.73M0.81230,509-6.76%-$5.78M0.42
Charles Schwab$77.28M0.78223,441+4.3%+$3.18M0.02
SEI Investments Company$64.55M0.65186,626+18.67%+$10.16M0.1
Artisan Partners$62.2M0.63179,840+18.56%+$9.74M0.09
Parsifal Capital Management Lp$61.57M0.62178,013-7.09%-$4.7M4.25
Allspring Global Investments$56.65M0.57163,783-1.41%-$810,719.860.09
Bellevue Group$54.17M0.55156,618+10.96%+$5.35M0.83
BNY Mellon$53.73M0.55155,360+16.01%+$7.42M0.01
Deerfield Management$52.7M0.53152,378+0.53%+$277,733.610.13
Legal & General$50.9M0.52147,160-2.94%-$1.54M0.01
GW&K Investment Management$47.69M0.48137,886+0.07%+$32,166.160.42
Mawer Investment Management Ltd$46.12M0.47133,353+7.65%+$3.28M0.21
Qvidtvm Management Llc$43.56M0.44125,938+0.72%+$311,283.003.09
Tikvah Management Llc$40.86M0.41118,1470%+$08.59
Nitorum Fund LP$38.62M0.39111,653-17.23%-$8.04M3.93
Deutsche Bank$36.82M0.37106,451+15.28%+$4.88M0.02
Fidelity Investments$36.38M0.37105,193-23.59%-$11.23M<0.01
First Pacific Advisors LP$36.23M0.37104,739+2,052.47%+$34.54M0.41
Anchor Capital Advisors LLC$34.6M0.35100,031+30.42%+$8.07M0.91
Southpoint Capital Advisors Lp$34.59M0.35100,000New+$34.59M0.68
Envestnet Asset Management Inc$34.54M0.3599,866-2.07%-$730,478.950.01
Grantham Mayo Van Otterloo & Co LLC$32.29M0.3393,352-5.79%-$1.98M0.1
Nuveen$31.69M0.3291,477+3.68%+$1.12M0.01
Portolan Capital Management$31.47M0.3290,992+58.87%+$11.66M2.42
Federated Hermes$31.19M0.3290,183+13.45%+$3.7M0.07
Fisher Asset Management Llc$28M0.2880,943+0.35%+$96,497.730.01
The Manufacturers Life Insurance Company$27.48M0.2879,464+7.95%+$2.02M0.03
Marathon Asset Management Limited$26.24M0.2775,857New+$26.24M0.7
Qube Research & Technologies$25.17M0.2672,770-57.17%-$33.6M0.03
Boone Capital Management Llc$25.02M0.2572,344+102.57%+$12.67M5.06
Franklin Templeton Investments$25.05M0.2572,423+281.17%+$18.48M0.01
Point72 Asset Management$24.7M0.2571,400New+$24.7M0.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.